Preclinical Evaluation of an Anchored Immunotherapy Strategy with Aluminum Hydroxide–Tethered IL-12 in Dogs with Advanced Malignant Melanoma

Post time 6 day(s) ago

journal：Molecular Cancer Therapeutics

Authors：Matheus Moreno Passos Barbosa; Rebecca L. Kamerer; Joanna Schmit; Angel J. Lopez; Rachel Uyehara; Robert Tighe; Sailaja Battula; Howard L. Kaufman; Timothy M. Fan

Published date：2025-3-4

DOI：10.1158/1535-7163.mct-24-0317

PDF link：https://aacrjournals.org/mct/art ... 782/mct-24-0317.pdf

Article link：https://doi.org/10.1158/1535-7163.mct-24-0317

Article Source：American Association for Cancer Research (AACR)。

Remark：

Post time 6 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AACR] Preclinical Evaluation of an Anchored Immunotherapy Strategy with Aluminum Hydroxide–Tethered IL-12 in Dogs with Advanced Malignant Melanoma

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AACR] Preclinical Evaluation of an Anchored Immunotherapy Strategy with Aluminum Hydroxide–Tethered IL-12 in Dogs with Advanced Malignant Melanoma Copy